PRQR

#6352
ProQR Therapeutics N.V. Ordinary Shares
1.59
+3.25%
版块:
基础:
利润货币:
日范围
1.59
1.59
年范围
1.07
3.10
日变化
+3.25%
每月变动
-4.79%
6个月变化
-28.05%
年变化
-32.91%
前一天收盘价
1.54
Open
1.59
Bid
Ask
Low
1.59
High
1.59
交易量
6
Open full chart

Financials

Overview 声明 Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 166
  • Founded 2012
  • CEO Daniel A. de Boer
  • Website www.proqr.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

ProQR Therapeutics N.V

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

新闻